somat
cell
undergo
chang
genom
epigenom
lifetim
accumul
chang
involv
regul
cell
growth
death
result
unchart
growth
may
alter
normal
somat
cell
turn
cancer
cell
carcinogenesi
process
malfunct
gene
includ
gain
function
protooncogen
loss
function
tumor
suppressor
gene
cancer
cell
exhibit
hallmark
alter
physiolog
name
selfsuffici
growth
signal
insensit
growth
inhibitori
signal
evas
program
cell
death
limitless
replic
potenti
reprogram
cellular
energet
induct
angiogenesi
presenc
tumorpromot
inflamm
avoid
immun
destruct
mainten
genom
instabl
mutat
activ
tissu
invas
metastasi
hanahan
weinberg
cancer
multistep
process
may
take
decad
develop
carcinogenesi
trace
initi
follow
promot
progress
metastasi
accumul
hand
mutat
adequ
cancer
develop
cancer
cell
selfrenew
migrat
invad
clonal
expans
complex
tissu
ecosystem
greav
maley
nich
microenviron
surround
cancer
cell
shape
path
carcinogenesi
exampl
host
immun
system
attempt
destroy
develop
cancer
although
result
may
vari
seen
outcom
cancer
immunoedit
schreiber
et
al
tumor
evolv
benign
malign
final
lead
death
host
cancer
patient
investig
interest
detail
process
carcinogenesi
way
halt
progress
dietari
phytochem
shown
modul
carcinogenet
process
histolog
examin
tumor
heterogen
compos
tumor
cell
variou
stage
cell
differenti
plu
nontumor
cell
fibroblast
immun
cell
thu
cell
within
tumor
equal
clonal
evolut
competit
within
tumor
result
domin
cell
resist
therapi
selfrenew
differenti
progeni
cell
observ
tumor
heterogen
explain
cancer
stem
cell
csc
hypothesi
workshop
american
associ
cancer
research
settl
consensu
definit
csc
cell
within
tumor
possess
capac
selfrenew
caus
heterogen
lineag
cancer
cell
compris
tumor
clark
et
al
put
csc
also
known
tumoriniti
cell
term
prefer
investig
seen
exampl
tumoriniti
cell
popularli
known
cancer
stem
cell
zhou
et
al
chapter
use
popular
term
csc
review
publish
abstract
start
stem
cell
biolog
come
age
end
cancer
cell
may
includ
cancer
stem
cell
cell
indefinit
potenti
selfrenew
drive
tumorigenesi
reya
et
al
research
variou
aspect
csc
report
interven
year
addit
research
review
public
csc
topic
edit
monograph
first
book
dedic
csc
came
bapat
editor
scientist
india
first
isol
human
ovarian
csc
bapat
et
al
volum
subsequ
appear
farrar
allan
scatena
et
al
one
address
csc
method
yu
even
webpublish
volum
shostak
seri
dedic
cancer
cell
csc
hayat
csc
biolog
come
age
realiti
csc
hypothesi
csc
concept
long
histori
subject
bill
old
concept
new
insight
vermeulen
et
al
evolv
concept
nguyen
et
al
link
stem
cell
cancer
histolog
similar
note
embryon
tumor
tissu
nineteenth
centuri
becam
embryon
rest
theori
cancer
aris
cell
properti
similar
earli
embryo
later
investig
conclud
cancer
view
caricatur
normal
develop
unchart
cell
prolifer
seen
cancer
result
distort
normal
develop
lack
coordin
growth
differenti
nguyen
et
al
addit
knowledg
stem
cell
biolog
normal
tissu
translat
concept
csc
cancer
tissu
perhap
best
known
normal
stem
cell
hematopoiet
stem
cell
hsc
hsc
hierarchi
permit
organ
process
selfrenew
differenti
give
rise
progeni
differenti
cell
type
includ
erythrocyt
macrophag
lymphocyt
mani
other
immunologist
identifi
cluster
differenti
cd
marker
differ
cell
type
cell
surfac
antigen
allow
isol
cell
method
fluorescenceactiv
cell
sort
fac
rare
hsc
exhibit
surfac
marker
member
famili
singlepass
transmembran
sialomucin
protein
note
although
seen
human
hsc
mous
equival
thu
speci
differ
cd
distribut
studi
hematopoiet
malign
jacob
furth
morton
kahn
provid
first
quantit
assay
assess
frequenc
cancer
cell
maintain
hematopoiet
tumor
show
singl
mous
leukem
cell
capabl
transmit
system
diseas
transplant
recipi
mous
quot
clever
definit
csc
murin
leukemia
like
murin
counterpart
human
csc
first
demonstr
leukemia
extend
solid
tumor
bonnet
dick
report
presenc
csc
human
acut
myeloid
leukemia
isol
patient
csc
reconstitut
leukemia
transplant
immunodefici
mice
alhajj
et
al
report
presenc
human
breast
cancer
wrote
cell
phenotyp
abl
form
tumor
mice
wherea
ten
thousand
cell
altern
phenotyp
fail
form
tumor
singh
et
al
report
presenc
csc
human
brain
cancer
comment
increas
selfrenew
capac
brain
tumor
stem
cell
btsc
highest
aggress
clinic
sampl
medulloblastoma
compar
lowgrad
glioma
btsc
exclus
isol
cell
fraction
express
neural
stem
cell
surfac
marker
cell
could
differenti
cultur
tumor
cell
phenotyp
resembl
tumor
patient
initi
studi
csc
expand
mani
cancer
follow
decad
cellular
antigen
csc
serv
biomark
common
one
woodward
sulman
keysar
jimeno
use
isol
csc
leukemia
breast
cancer
mani
cancer
heatstabl
antigen
sialoprotein
act
ligand
thu
enabl
cell
bind
platelet
protect
tumor
cell
blood
stream
although
neg
breast
csc
present
ovarian
csc
gao
et
al
transmembran
glycoprotein
hyaluron
acid
receptor
besid
breast
cancer
found
csc
pancreat
gastric
head
neck
ovarian
colon
cancer
also
name
glycoprotein
consist
five
transmembran
domain
restrict
express
within
plasma
membran
protrus
site
addit
brain
cancer
found
csc
colon
liver
pancreat
prostat
cancer
alison
et
al
zobalova
et
al
hu
fu
note
antigen
also
present
respect
normal
stem
cell
although
use
biomark
cancer
counterpart
henc
signific
csc
marker
seen
endur
ambigu
jaggupilli
elkord
anoth
import
point
lack
singl
cd
antigen
common
csc
howev
univers
marker
may
close
hand
recent
drug
screen
studi
specif
target
csc
dopamin
receptor
discov
biomark
csc
normal
stem
cell
leukem
breast
csc
test
far
novel
biomark
requir
confirm
valid
sachlo
et
al
addit
identif
biomark
csc
also
character
function
assay
name
detect
side
popul
sp
activ
assess
aldehyd
dehydrogenas
aldh
activ
keysar
jimeno
tirino
et
al
sp
assay
measur
abil
cell
expel
fluoresc
dye
hoechst
caus
activ
atpdepend
drug
transport
plasma
membran
especi
transport
mo
zhang
analyz
flow
cytometri
cell
fast
drug
exit
form
side
popul
oppos
main
popul
compos
major
cell
initi
identifi
hsc
sp
found
mani
csc
similarli
aldh
detoxifi
enzym
act
oxid
aldehyd
carboxyl
acid
metabol
liver
exit
fluoresc
substrat
assay
use
aldefluor
biodipyaminoacetaldehyd
baaa
allow
isol
aldh
cell
aldh
assay
initi
use
isol
hsc
normal
breast
stem
cell
extend
csc
ginesti
et
al
inasmuch
sp
aldh
assay
involv
drug
extrus
metabol
exhibit
capac
indic
drug
resist
normal
csc
exampl
sp
aldh
assay
addit
specif
biomark
screen
util
identif
human
ovarian
csc
summar
bapat
howev
emphas
assay
enrich
csc
biomark
function
assay
may
character
csc
analyz
sampl
therefor
addit
csc
exhibit
attribut
test
may
still
present
list
biomark
current
use
isol
cancer
stem
cell
pleas
see
tabl
addit
biomark
function
assay
anoth
vitro
method
studi
csc
use
serumfre
sphere
spheroid
cultur
tissu
cultur
cell
usual
grown
monolay
nutrientrich
medium
contain
fetal
bovin
serum
sourc
necessari
growth
factor
compon
howev
absenc
serum
presenc
growth
factor
fibroblast
growth
factor
fgf
epiderm
growth
factor
egf
cell
grow
sphere
suspens
unattacheduntr
tissu
cultur
plastic
dish
flask
plate
spheroid
cultur
mimic
threedimension
natur
tissu
furthermor
note
oxygen
less
avail
cell
locat
interior
sphere
hypox
condit
may
modul
differenti
state
toward
stem
origin
develop
neurobiolog
studi
spheroid
cultur
use
identifi
stem
cell
base
report
capac
evalu
selfrenew
differenti
singlecel
level
vitro
pastrana
et
al
spheroid
cultur
develop
normal
tissu
tumor
chen
et
al
isol
individu
sphereform
cell
tumor
form
secondari
tertiari
sphere
upon
sequenti
subcultur
oper
definit
csc
howev
critiqu
spheroid
assay
sphere
prone
aggreg
henc
cell
densiti
influenc
clonal
quiescent
stem
cell
may
miss
method
pastrana
et
al
fact
quiescent
natur
put
normal
csc
util
character
cell
known
labelretain
cell
retain
label
lipophil
dye
dilut
subsequ
cell
divis
slowdivid
cell
pece
et
al
xin
et
al
tumor
sampl
put
csc
may
character
vitro
techniqu
discuss
addit
isol
csc
tumor
sampl
also
possibl
isol
establish
cancer
cell
line
drewa
et
al
mather
advantag
latter
absenc
nontumor
cell
contamin
disadvantag
addit
accumul
chang
long
period
vitro
cultur
exampl
interest
csc
sp
analysi
led
us
isol
sp
rat
glioma
cell
line
deriv
put
csc
establish
cell
line
fong
et
al
howev
stem
state
dynam
although
sp
give
rise
sp
nonsp
progeni
expect
nonsp
fong
et
al
fong
chan
complementari
vitro
studi
csc
vivo
model
avail
isol
cell
test
abil
initi
new
tumor
growth
xenotransplant
immunocompromis
mice
cheng
et
al
limit
dilut
xenotransplant
yield
estim
csc
abund
tumor
sampl
sequenti
transplant
yield
origin
tumor
confirm
presenc
csc
differ
murin
model
vari
degre
immunodefici
appli
csc
studi
exampl
includ
athym
nude
mice
nonobes
diabeticsever
combin
immunodefici
nodscid
mice
nodscid
receptor
gamma
chain
null
mice
exampl
use
sever
immunodefici
nodscid
mice
singlecel
transplant
appropri
extracellular
matrix
matrigel
human
melanoma
sampl
unselect
melanoma
cell
develop
tumor
mice
quintana
et
al
find
detect
abund
human
skin
csc
wherea
csc
cancer
rare
critiqu
xenotransplant
assay
place
human
cancer
cell
immunodefici
mice
artifici
human
cancer
cell
encount
normal
host
immun
respons
therefor
result
assay
reflect
physiolog
fate
csc
nativ
environ
despit
object
limit
dilut
murin
vivo
xenotransplant
assay
held
gold
standard
csc
identif
ghiaur
et
al
howev
vivo
assay
attempt
identifi
csc
one
exampl
zebrafish
model
blackburn
et
al
nonetheless
found
quot
despit
consid
gold
standard
assay
csc
mani
field
reason
assum
growth
immunocompromis
mice
fact
relev
assay
csc
activ
ghiaur
et
al
even
csc
hypothesi
controversi
one
review
ask
cancer
stem
cell
mirag
realiti
gupta
et
al
anoth
discuss
cancer
stem
cell
cancer
nonstem
cell
adult
stem
cell
reprogram
differenti
somat
cell
trosko
third
comment
investig
studi
cancer
stem
cell
csc
receiv
enorm
attent
past
year
remain
topic
consider
controversi
rosen
jordan
similar
statement
made
investig
studi
csc
receiv
enorm
attent
past
year
remain
topic
consider
controversi
opinion
valid
csc
hypothesi
biolog
properti
csc
relev
csc
cancer
therapi
differ
wide
tirino
et
al
howev
accumul
evid
favor
csc
hypothesi
csc
may
explain
concept
cancer
therefor
relev
cancer
therapi
major
support
data
presenc
csc
minim
residu
diseas
mrd
demonstr
csc
cell
lineag
trace
studi
murin
tumor
mrd
term
first
use
leukemia
denot
small
number
leukem
cell
remain
patient
treatment
patient
remiss
symptomssign
diseas
major
caus
relaps
cancer
mrd
appli
solid
tumor
csc
resist
therapi
enrich
chemo
radiotherapi
found
mrd
shown
case
exampl
resid
breast
csc
popul
surviv
convent
treatment
docetaxel
found
enrich
breast
csc
express
epithelialmesenchymaltransit
emt
gene
creighton
et
al
thu
presenc
csc
therapi
predict
recurr
ghiaur
et
al
lineag
trace
common
techniqu
studi
cell
origin
development
biolog
track
cell
fluoresc
protein
green
fluoresc
protein
gfp
three
differ
murin
solid
tumor
report
cheer
resolv
stemcel
debat
gilbertson
graham
murin
intestin
adenoma
cell
csc
exhibit
marker
leucinerich
repeatcontain
heterotrimer
guanin
nucleotidebind
proteincoupl
receptor
cell
lineag
trace
made
possibl
use
crereport
locu
show
fluoresc
four
color
green
red
yellow
blue
even
color
convers
tumor
develop
cell
gener
addit
cell
well
adenoma
cell
type
scheper
et
al
murin
papilloma
benign
skin
tumor
cell
stem
cell
track
yellow
fluoresc
protein
divid
twice
day
wherea
other
becam
termin
differenti
tumor
cell
driessen
et
al
murin
glioblastoma
transgen
creat
label
quiescent
adult
neural
stem
cell
subset
endogen
glioma
tumor
cell
express
gfp
transgen
also
contain
viral
thymidin
kinas
gene
could
target
drug
ganciclovir
glioma
treat
drug
temozolomid
tmz
tmz
treatment
alon
led
regrowth
subpopul
csc
control
ganciclovir
tmzganciclovir
cotreat
imped
tumor
develop
destroy
cancer
cell
csc
henc
last
studi
demonstr
exist
murin
glioma
csc
select
target
chen
et
al
assumpt
find
mice
extrapolat
human
demonstr
csc
murin
glioma
tmzganciclovir
cotreat
show
clinic
relev
csc
csc
resist
therapi
becom
chemo
radioresist
therapeut
treatment
donnenberg
donnenberg
kraus
et
al
characterist
due
activ
drug
transport
metabol
enzym
dna
repair
system
activ
genom
instabl
csc
may
possess
less
reactiv
oxygen
speci
ro
thu
less
suscept
radiat
therapi
diehn
et
al
depend
individu
case
cancer
csc
may
aris
either
mutat
normal
stem
cell
dedifferenti
cancer
cell
exhibit
stem
cell
featur
display
pathway
gene
express
common
normal
stem
cell
therefor
think
along
therapeut
approach
compound
target
csc
must
capabl
differenti
normal
stem
cell
spare
latter
otherwis
unforeseen
problem
normal
tissu
homeostasi
occur
sever
signal
transduct
pathway
activ
csc
may
amen
intervent
selfrenew
pathway
seen
csc
relat
express
protein
involv
hedgehog
wnt
notch
signal
addit
pathway
includ
pathway
garvalov
acker
alison
et
al
hu
fu
hedgehog
hh
signal
pathway
start
secret
morphogenet
factor
term
hh
come
fruit
fli
genet
mutat
hh
lead
spinylook
larva
gene
essenti
arthropod
segment
mammalian
develop
mammalian
hh
morphogen
ligand
bind
receptor
patch
bind
activ
anoth
plasma
membran
protein
smoothen
eventu
lead
activ
transcript
factor
known
gli
glioma
wnt
signal
pathway
also
start
secret
morphogenet
factor
term
wnt
come
fruit
fli
genet
mutat
wingless
wg
import
arthropod
polar
segment
murin
gene
integr
gene
activ
breast
cancer
mice
infect
mous
mammari
tumor
viru
wnt
morphogen
bind
receptor
seri
intermedi
step
result
mobil
cytoskelet
protein
betacatenin
cytoplasm
nucleu
activ
specif
transcript
factor
known
lymphoid
enhanc
bind
factortcel
factor
leftcf
instead
secret
factor
notch
signal
pathway
start
membraneassoci
notch
protein
term
notch
also
come
fruit
fli
genet
mutat
result
notch
fli
wing
bind
notch
ligand
membran
protein
delta
neighbor
cell
initi
pathway
notch
protein
undergo
limit
proteolysi
proteinas
name
gammasecretas
yield
notch
intracellular
domain
nicd
mobil
cytoplasm
nucleu
activ
specif
transcript
factor
name
recombin
signal
bind
protein
immunoglobulin
kappa
j
rbpj
alia
csl
mammalian
centromer
promot
bind
factor
fruit
fli
suppressor
hairless
mutat
nematod
gene
notch
gene
mutationspolymorph
found
cancer
patient
may
involv
csc
chemoresist
crea
et
al
three
signal
pathway
initi
hedgehog
wnt
notch
function
embryon
stem
cell
develop
may
dysregul
csc
activ
stem
cell
signal
pathway
result
express
stem
gene
pluripot
csc
exampl
octamerbind
transcript
factor
homeodomain
transcript
factor
nanog
homeobox
protein
anoth
transcript
factor
sex
determin
region
ybox
transcript
factor
high
mobil
group
domain
commonli
found
aggress
poorli
differenti
tumor
benporath
et
al
besid
hedgehog
wnt
notch
pathway
addit
one
alison
et
al
phosphoinositid
link
mammalian
target
rapamycin
mtor
relat
cellular
energet
signal
pathway
lead
activ
nuclear
factor
kappa
b
import
cytokin
express
inflammatori
respons
activ
pathway
result
express
stem
phenotyp
csc
prolifer
differenti
may
becom
resist
treatment
chemic
radiat
molecul
target
pathway
especi
dietari
phytochem
discuss
respect
csc
normal
stem
cellscsc
resid
specif
place
cell
influenc
surround
environ
local
ecosystem
concept
known
stem
cell
microenviron
stem
cell
nich
thu
normal
stem
cell
cancer
stem
cell
nich
matter
li
neav
locat
locat
locat
cancer
stem
cell
nich
sneddon
werb
resid
cell
affect
nich
best
character
normal
stem
cell
hsc
behav
differ
depend
nich
bone
nich
hsc
quiescent
bone
marrow
vascular
nich
hsc
undergo
prolifer
differenti
within
blood
vessel
similarli
nich
concept
appli
csc
addit
primari
tumor
site
secondari
tumor
site
tumor
metastasi
tumor
site
consist
varieti
cellular
extracellular
compon
addit
cancer
cell
csc
cell
type
includ
blood
lymphat
endotheli
cell
fibroblast
adipocyt
immun
inflammatori
cell
cell
may
secret
molecul
either
promot
inhibit
tumor
depend
chang
microenviron
cytokin
chemotact
factor
extracellular
matrix
produc
variou
cell
affect
behavior
cancer
cell
chang
alway
occur
within
tumor
nich
dynam
exampl
cancerassoci
fibroblast
tumorinfiltr
macrophag
separ
macrophag
subset
pro
antiinflammatori
attribut
respect
protect
facilit
tumor
develop
furthermor
nich
within
tumor
hypox
hypoxia
determin
csc
csc
may
express
hypoxiainduc
factor
et
al
biolog
tumor
understood
studi
tumor
cell
heterogen
nich
construct
cours
carcinogenesi
henc
situat
becom
bed
bug
interact
tumor
microenviron
cancer
stem
cell
et
al
interdepend
csc
nich
exampl
paracrin
signal
carcinoma
cell
mesenchym
stem
cell
msc
report
li
et
al
rasanen
herlyn
msc
recruit
tumor
nich
carcinoma
cell
produc
cytokin
induc
msc
produc
lipid
molecul
prostaglandin
chang
carcinoma
cell
activ
betacatenin
signal
pathway
format
csc
via
process
known
transit
emt
exampl
suggest
nich
allow
csc
develop
cell
commun
within
epitheli
cell
layer
compris
gap
junction
intercellular
commun
gjic
essenti
featur
cellular
homeostasi
trosko
emt
epitheli
cell
undergo
transform
becom
mesenchym
natur
tightli
pack
highli
differenti
immobil
cell
loos
pack
less
differenti
mobil
cell
special
group
transcript
factor
activ
includ
snail
slug
name
fruit
fli
zinc
finger
gene
regulatori
protein
adhes
protein
ecadherin
e
epitheli
downregul
lead
motil
cell
absenc
ecadherin
also
allow
drug
resist
elev
express
associ
high
drug
sensit
within
tumor
activ
emt
program
gener
reservoir
csc
emt
enhanc
cell
surviv
express
gene
aid
cell
avoid
apoptosi
program
cell
death
anoiki
cell
death
due
loss
cell
adhes
cellular
senesc
process
limit
cell
replic
even
host
immun
respons
tiwaria
et
al
scheel
weinberg
addit
contribut
express
stem
cell
phenotyp
emt
facilit
earli
stage
cancer
cell
invas
metastasi
csc
within
primari
tumor
leav
locat
colon
distant
site
thu
metastasi
major
caus
human
cancer
death
csc
may
genet
unstabl
multipl
csc
clone
may
present
within
tumor
intrins
genet
alter
keep
cell
emt
stem
state
baccelli
trumpp
migrat
secondari
site
cell
may
convert
back
epitheli
state
transit
met
occur
revers
process
less
well
character
nonetheless
phenotyp
plastic
process
brabletz
interact
among
cancer
csc
mitochondria
almost
mammalian
cell
mitochondria
subcellular
organel
except
matur
erythrocyt
mitochondria
essenti
cell
metabol
tumor
cell
mitochondria
resist
apoptosisassoci
permeabil
tumor
cell
mitochondria
also
contribut
alter
cell
metabol
stimul
cell
growth
anabol
metabol
tumor
cell
metabol
becom
target
cancer
treatment
kroemer
pouyssegur
earli
discoveri
tumor
metabol
becam
known
warburg
effect
otto
warburg
report
increas
glycolysi
leukem
solid
tumor
cell
domin
work
may
delay
investig
cancer
mitochondria
time
howev
recent
studi
mitochondri
enzym
metabol
shown
play
signific
pathogen
role
cancer
scatena
cell
experi
stress
mitochondria
respond
rapid
mitochondri
fission
fusion
depend
gtpase
notabl
dynaminrel
promot
fission
promot
fusion
process
lead
elimin
damag
via
fission
compens
damag
via
fusion
defect
mitochondria
destroy
via
autophagi
known
mitophagi
els
fail
stress
cell
undergo
apoptosi
youl
van
der
bliek
mitochondria
fission
import
cancer
demonstr
lung
cancer
use
human
lung
adenocarcinoma
cell
line
xenograft
nude
mice
gene
therapi
adenoviru
vector
lead
smaller
tumor
compar
control
cancer
cell
similar
tumor
size
reduct
also
seen
pharmacolog
approach
use
select
inhibitor
mitochondri
divis
yeast
mammalian
cell
thu
impair
fusion
enhanc
fission
contribut
proliferationapoptosi
imbal
cancer
rehman
et
al
target
cancer
cell
mitochondria
gener
develop
group
compound
known
mitocan
mitochondri
target
anticanc
drug
one
exampl
alphatocopheryl
succin
analogu
vitamin
e
neuzil
et
al
thu
far
metabol
differ
normal
cancer
cell
mitochondria
shown
latter
may
therapeut
target
cancer
relationship
csc
breast
csc
deriv
human
breast
cancer
cell
line
suscept
mitochondri
target
vitamin
e
succin
name
mitov
vitro
addit
propos
csc
marker
may
select
stem
cell
evad
host
immun
respons
overcom
stressinduc
apoptosi
via
mitochondri
connect
zobalova
et
al
studi
use
breast
csc
xenograft
nodscid
mice
mitochondri
target
liposom
carri
daunorubicin
quinacrin
inhibit
tumor
develop
zhang
et
al
summari
csc
target
mitochondri
drug
occup
cancer
first
identifi
percival
pott
young
chimney
sweep
later
got
scrotal
cancer
work
nake
avoid
dirti
cloth
remedi
wear
cloth
chimney
work
clean
bath
afterward
measur
follow
holland
england
result
individu
less
scrotal
cancer
respect
prevent
cancer
becam
topic
interest
concept
chemoprophylaxi
chemoprotect
began
propos
michael
sporn
introduc
word
chemoprevent
investig
vitamin
analogu
becam
commonli
accept
term
sporn
suh
lippman
hawk
chemoprevent
refer
use
agent
inhibit
revers
delay
tumorigenesi
fruit
veget
intak
part
human
diet
omnivor
human
also
consum
variou
meat
food
bioactiv
compon
plant
nonnutri
dietari
phytochem
may
modul
gene
express
signal
transduct
pathway
manson
surh
tan
et
al
phytochem
isol
character
fruit
grape
appl
veget
broccoli
onion
spice
turmer
beverag
green
tea
red
wine
well
numer
sourc
collect
compound
becam
known
chemoprevent
agent
chemoprevent
agent
phytochem
shown
interact
multipl
cellular
target
aggarw
shishodia
lee
et
al
even
epigenom
vanden
bergh
respect
chemoprevent
phytochem
target
inflamm
murakami
ohigashi
kim
et
al
import
inflamm
may
initi
cancer
loss
cell
cycl
control
meeran
katiyar
addit
chemoprevent
phytochem
applic
cancer
therapi
molecular
mechan
may
common
chemoprevent
cancer
therapi
phytochem
may
modul
cancer
develop
even
metastasi
pan
ho
gupta
et
al
among
divers
phytochem
implic
inhibit
carcinogenesi
one
major
group
compris
polyphenol
compound
virtual
ubiquit
plant
materi
may
occur
high
level
mostli
synthes
phenylalanin
plant
phenol
serv
structur
polym
compon
also
respons
ultraviolet
light
screen
antioxid
activ
act
signal
molecul
import
role
plant
phenol
may
plant
defens
pathogen
herbivor
predat
discoveri
health
benefit
plant
polyphenol
propos
optim
phenol
content
diet
obtain
favor
consequ
gener
health
popul
parr
bolwel
within
plant
phenol
one
group
import
chemoprevent
known
flavonoid
yao
et
al
anoth
group
classifi
phytoestrogen
moutsats
phytochem
action
csc
discuss
follow
section
csc
known
resist
chemotherapi
previous
review
overcom
cancer
drug
resist
phytochem
chan
fong
relev
inform
phytochem
discuss
earlier
updat
incorpor
chapter
curcumin
diferuloylmethan
indian
spice
turmer
see
figur
chemic
structur
curcumin
respons
yellow
color
curri
powder
turmer
produc
rhizom
plant
curcuma
longa
addit
use
spice
turmer
multipl
applic
tradit
asian
indian
medicin
rang
treat
insect
bite
wound
heal
multipl
health
benefit
associ
curcumin
turmer
summar
monograph
aggarw
et
al
mani
review
strimpako
sharma
goel
et
al
multipl
divers
bioactiv
attribut
curcumin
includ
cancer
chemoprevent
antiinflammatori
activ
bisht
et
al
curcumin
act
mani
cellular
target
ravindran
et
al
includ
enzym
cyclooxygenas
lipoxygenas
induc
nitric
oxid
synthas
ino
transcript
factor
activ
cytokin
tumor
necrosi
factor
tnf
mani
gene
product
link
cell
surviv
prolifer
invas
angiogenesi
exampl
found
curcumin
inhibit
tnf
human
monocyt
cell
line
mono
mac
endotoxininduc
murin
sepsi
model
curcumin
ingest
gavag
induc
bioactiv
shown
downregul
ino
gene
express
murin
liver
chan
chan
et
al
synergist
effect
curcumin
chemotherapeut
drug
demonstr
shown
curcumin
enhanc
cisplatinmedi
kill
human
ovarian
cancer
cell
line
vitro
chan
et
al
chan
fong
end
section
note
curcumin
patent
march
uspto
award
patent
use
turmer
wound
heal
us
patent
suman
da
hari
har
cohli
univers
mississippi
assigne
patent
withdrawn
august
protest
india
council
scientif
industri
research
csir
demonstr
lack
novelti
criterion
requir
patent
inasmuch
turmer
use
centuri
indian
popul
wound
heal
jayaraman
wherea
csc
drug
radiationresist
curcumin
chemosensit
radiosensit
tumor
goel
aggarw
howev
also
point
dark
side
curcumin
et
al
note
potenti
turmer
consumpt
reduc
risk
cancer
hutchinswolfbrandt
mistri
effect
curcumin
csc
shown
use
sp
select
csc
rat
glioma
cell
line
vitro
found
curcumin
daili
day
via
medium
chang
reduc
sp
like
via
inhibit
drug
transport
fong
et
al
curcumin
target
human
glioblastoma
csc
vitro
vivo
latter
via
intracrani
implant
human
csc
intraperiton
inject
curcumin
mgkg
everi
day
week
investig
propos
mechan
induct
autophagi
promot
differenti
zhuang
et
al
curcumin
target
csc
human
esophag
squamou
carcinoma
cell
line
vitro
show
decreas
aldehyd
dehydrogenas
aldh
activ
well
express
almanaa
et
al
curcumin
inhibit
spheroid
cultur
human
esophag
csc
vitro
via
notch
signal
pathway
subramaniam
et
al
human
breast
csc
cell
line
normal
breast
stem
cell
target
curcumin
togeth
anoth
phytochem
piperin
black
pepper
decreas
spheroid
cultur
number
well
decreas
aldh
activ
kakarala
et
al
normal
csc
affect
therefor
potenti
phytochem
cancer
therapi
effect
normal
stem
cell
must
clearli
differenti
csc
curcumin
complement
drug
vitro
cotreat
curcumin
folfoxfuox
fluorouracil
oxaliplatin
day
inhibit
spheroid
cultur
human
colon
csc
cell
line
yu
et
al
induct
apoptosi
human
brain
tumor
stem
cell
commerci
avail
celprogen
vitro
shown
cotreat
curcumin
paclitaxel
nm
hossain
et
al
result
show
feasibl
combin
convent
drug
phytochem
target
csc
clinic
cancer
howev
solubl
curcumin
concern
overcom
hurdl
variou
carrier
develop
polymer
nanoparticl
formul
curcumin
nanocurcumin
trademark
nanocurc
induc
apoptosi
reduc
stem
cell
malign
brain
tumor
vitro
lim
et
al
hyaluron
acid
ha
base
nanogelcurcumin
conjug
use
cholesterylha
time
higher
cytotox
curcumin
alon
toward
human
pancreat
csc
express
wei
et
al
author
also
report
similar
effect
nanogeldrug
conjug
two
compound
target
csc
name
etoposid
salinomycin
novel
micel
formul
curcumin
compos
stearic
acidgchitosan
oligosaccharid
csosa
polymer
biocompat
biodegrad
drug
carrier
inhibit
colorect
csc
vitro
vivo
nude
mice
xenograft
latter
dose
mgkg
daili
day
experi
wang
et
al
anoth
approach
curcumin
solubl
synthes
analogu
difluorinatedcurcumin
cdf
inhibit
spheroid
cultur
human
colon
csc
cell
line
vitro
kanwar
et
al
cdf
plu
folfoxfuox
fluorouracil
oxaliplatin
inhibit
growth
colorect
cancer
cell
line
csc
vitro
via
downregul
promot
differenti
yu
et
al
monoketon
analogu
curcumin
sato
et
al
inhibit
human
colorect
csc
cell
line
vitro
induc
apoptosi
vivo
nodscid
mice
xenograft
latter
dose
mgkg
daili
day
experi
lin
et
al
result
show
human
csc
target
curcumin
analogu
vivo
use
mous
model
resveratrol
stilben
exact
red
wine
grape
peanut
pine
nut
see
fig
chemic
structur
resveratrol
red
wine
made
whole
grape
includ
grape
skin
fruit
grape
vine
plant
viti
venifera
relat
speci
resveratrol
present
red
wine
molecul
associ
skin
portion
fruit
fight
fungal
infect
plant
exampl
phytoalexin
compound
produc
plant
pathogen
similar
plant
fungal
pathogen
demonstr
activ
human
dermal
fungal
pathogen
resveratrol
may
use
treat
athlet
foot
chan
health
benefit
associ
resveratrol
summar
monograph
aggarw
shishodia
mani
review
athar
et
al
gescher
harikumar
aggarw
kundu
surh
saiko
et
al
one
molecul
mani
target
pirola
resveratrol
recent
claim
fame
involv
action
activ
sirtuin
deacetylas
lead
lifespan
extens
organ
divers
yeast
nematod
fruit
fli
fish
baur
sinclair
resveratrol
prior
claim
fame
involv
phenomenon
known
french
paradox
opi
lecour
refer
observ
french
benefit
rel
low
risk
develop
cardiovascular
diseas
despit
diet
high
satur
fat
resveratrol
improv
gener
health
mice
seem
delay
age
paramet
barger
et
al
pearson
et
al
sens
mimic
phenomenon
known
calor
restrict
method
retard
aspect
age
process
mammal
maxmen
inde
antiinflammatori
activ
bisht
et
al
show
health
benefit
especi
cardioprotect
cancer
chemoprevent
respect
french
paradox
believ
resveratrol
alcohol
red
wine
may
part
reason
shown
synergist
effect
resveratrol
alcohol
inhibit
ino
chan
et
al
moder
consumpt
red
wine
may
benefici
human
health
end
section
commerci
note
april
fda
grant
orphan
drug
statu
resveratrol
treatment
mela
syndrom
mitochondri
encephalomyopathi
lactic
acidosi
strokelik
episod
caus
mitochondri
dna
mutat
sponsor
sirtri
pharmaceut
compani
massachusett
expertis
resveratrol
analogu
resveratrol
formul
orphan
drug
design
provid
compani
seven
year
market
exclus
late
april
sirtri
purchas
glaxosmithklin
million
decemb
sirtri
announc
clinic
trial
halt
studi
synthet
resveratrolmimick
drug
would
continu
current
role
resveratrol
antiag
molecul
seem
doubt
wade
howev
must
emphas
resveratrol
possess
cancer
chemoprevent
properti
difficulti
seem
decid
dietaryrelev
dose
scott
et
al
effect
resveratrol
csc
shown
includ
csc
acut
myeloid
leukemia
aml
brain
breast
head
neck
pancreat
cancer
inasmuch
resveratrol
multipl
cellular
target
sever
cellular
target
csc
reveal
aml
patient
increas
cytokin
interleukin
plasma
induc
activ
sonic
hedgehog
signal
pathway
shown
human
cell
line
resveratrol
inhibit
activ
decreas
cell
viabil
su
et
al
malign
brain
tumor
medulloblastoma
csc
grown
spheroid
cultur
resveratrol
inhibit
prolifer
vitro
enhanc
radiosensit
lu
et
al
primari
central
nervou
system
atyp
teratoidrhabdoid
tumor
resveratrol
induc
apoptosi
isol
vitro
also
enhanc
radiosensit
vitro
resveratroltr
irradi
result
better
surviv
scid
mice
xenograft
experi
kao
et
al
glioblastoma
multiforma
comparison
cell
shown
involv
signal
transduc
activ
transcript
resveratrol
act
via
inhibit
cytokin
signal
pathway
csc
treat
vitro
resveratrol
irradi
result
better
surviv
scid
mice
effect
resveratrol
mimick
small
hairpin
sh
rna
yang
et
al
move
central
nervou
system
organ
breast
csc
target
resveratrol
use
csc
isol
cell
line
resveratrol
inhibit
spheroid
cultur
induc
apoptosi
mechan
involv
action
resveratrol
lipid
synthesi
downregul
fatti
acid
synthas
fa
luciferaseexpress
csc
show
smallers
tumor
nude
mice
xenograft
resveratrol
administr
mgkg
via
oral
gavag
intraperiton
inject
everi
day
experi
pandey
et
al
similar
result
report
investig
use
csc
isol
anoth
human
breast
cancer
cell
line
pandey
et
al
human
head
neck
cancer
resveratrol
elimin
aldehyd
dehydrogenas
aldh
activ
spheroid
format
epitheli
mesenchym
transit
emt
vitro
well
reduc
tumor
xenograft
volum
weight
vivo
immunodefici
mice
mgkg
daili
day
hu
et
al
human
pancreat
form
spheroid
cultur
express
stem
gene
nanog
activ
inhibit
resveratrol
vitro
special
transgen
mous
model
mice
design
develop
pancreat
ductal
adenocarcinoma
increas
size
pancrea
inhibit
resveratrol
mgkg
administ
day
week
month
addit
inhibit
stem
gene
alia
pluripot
maintain
factor
resveratrol
inhibit
emt
shankar
et
al
summari
resveratrol
aim
differ
cellular
target
csc
depend
cancer
type
egcg
polyphenol
green
tea
see
figur
chemic
structur
egcg
tea
made
leav
plant
camellia
sinensi
origin
china
egcg
major
green
tea
polyphenol
account
dri
weight
waterextract
materi
green
tea
convert
dimer
polym
black
tea
product
tea
one
popular
beverag
consum
world
multipl
health
benefit
associ
egcg
tea
consumpt
zaveri
yang
et
al
khan
mukhtar
includ
cancer
chemoprevent
well
reduct
atherosclerosi
hypercholesterolemia
alzheim
ageingrel
diseas
egcg
target
multipl
signal
pathway
exampl
report
egcg
inhibit
ino
gene
express
level
enzym
activ
level
chan
et
al
egcg
act
synergist
cisplatin
kill
ovarian
cancer
cell
even
cisplatinresist
cell
line
enhanc
cell
death
cisplatin
seen
presenc
egcg
cell
cultur
chan
et
al
end
section
commerci
note
octob
fda
approv
extract
green
tea
prescript
drug
topic
treatment
genit
wart
gross
et
al
extract
polyphenon
e
veregen
ointment
german
biotech
compani
medigen
market
partner
bradley
pharmaceut
inc
first
prescript
botan
herbal
drug
approv
fda
current
regulatori
polici
botan
product
well
fda
new
drug
applic
process
blumenth
effect
egcg
csc
shown
actual
earli
report
use
normal
stem
cell
spheroid
cultur
csc
follow
initi
work
normal
neurospher
rat
neurospher
egcg
relat
compound
inhibit
neurospher
adhes
migrat
chen
et
al
extend
csc
spheroid
cultur
epigallocatechin
egcg
without
gallat
moieti
polyphenon
character
green
tea
extract
prevent
cell
shed
mous
mammari
cancer
mammospher
vitro
mechan
propos
decreas
ro
product
downregul
matrix
et
al
egcg
inhibit
spheroid
cultur
human
neuroblastoma
c
cell
vitro
csc
exhibit
aldh
activ
well
express
stem
gene
nanog
nishimura
et
al
egcg
analogu
act
csc
sever
chemic
synthes
analogu
target
human
breast
csc
cultur
mammospher
cell
line
mechan
attribut
activ
ampactiv
protein
kinas
ampk
pathway
known
activ
pathway
metformin
mm
behav
way
chen
et
al
synergist
effect
egcg
anoth
phytochem
quercetin
csc
investig
human
pancreat
csc
egcg
inhibit
spheroid
cultur
emt
hedgehog
pathway
vitro
activ
synergist
quercetin
shown
increas
apoptosi
tang
et
al
anoth
public
investig
also
report
similar
effect
human
prostat
csc
tang
et
al
summari
egcg
act
csc
either
alon
concert
anoth
phytochem
genistein
isoflavon
exact
soybean
see
fig
chemic
structur
genistein
soybean
seed
legum
plant
glycin
max
origin
china
although
china
current
import
soybean
unit
state
believ
isoflavon
soyrich
food
contribut
lower
rate
prostat
breast
cancer
observ
china
japan
compar
western
countri
genistein
molecul
mani
cellular
target
includ
inhibit
pathway
modul
cell
cycl
induct
apoptosi
banerje
et
al
addit
genistein
classifi
phytoestrogen
howev
lipid
solubl
exhibit
low
oral
bioavail
pharmacokinet
studi
yang
et
al
furthermor
dark
side
whole
soy
stori
daniel
soybean
contain
proteinas
inhibitor
toxic
digest
also
peopl
may
develop
allerg
reaction
soy
end
section
interest
demonstr
transgener
effect
genistein
agouti
mous
model
note
color
chang
fur
use
epigenet
biosensor
nutrit
environment
alter
fetal
genom
dolinoy
matern
dietari
supplement
genistein
mgkg
diet
led
dna
hypermethyl
embryo
methyl
state
maintain
adulthood
thu
phytochem
genistein
modifi
epigenom
effect
start
earli
embryogenesi
dolinoy
et
al
effect
genistein
csc
shown
genistein
report
protein
tyrosin
kinas
inhibitor
vitro
studi
chronic
myelogen
leukemia
stem
progenitor
cell
sensit
genistein
normal
progenitor
cell
carlostella
et
al
human
prostat
cancer
csc
cell
line
target
genistein
vitro
aid
death
csc
docetaxel
work
csc
name
achil
heel
cancer
mccubrey
et
al
anoth
studi
prostat
cancer
extend
focu
vivo
xenograft
discov
cellular
target
inhibit
hedgehog
pathway
zhang
et
al
genistein
inhibit
spheroid
cultur
prostat
csc
cell
line
inhibit
tumor
develop
vivo
nude
mice
twice
weekli
genistein
andor
docetaxel
mgkg
experi
although
csc
resist
docetaxel
genistein
plu
docetaxel
decreas
tumor
volum
genistein
alon
anoth
interest
report
involv
feed
genistein
mice
concentr
present
soy
protein
isol
mgkg
food
montal
et
al
sera
genisteinf
anim
use
treat
human
breast
csc
cell
line
sera
ad
medium
spheroid
format
inhibit
suggest
factor
found
sera
mice
consum
genistein
activ
csc
molecular
detail
factor
character
howev
last
investig
interest
respect
chemoprevent
genistein
diet
lead
anim
factor
circul
inhibit
csc
sulforaphan
alia
isothiocyan
found
brassicac
veget
see
fig
chemic
structur
sulforaphan
broccoli
cabbag
cauliflow
brussel
sprout
kale
cultivar
plant
known
brassica
oleracea
common
veget
belong
plant
order
brassical
older
name
crucifera
also
name
crucif
cabbag
famili
wild
cabbag
origin
came
europ
broccoli
relat
veget
contain
mani
phytochem
latt
et
al
addit
sulforaphan
compound
quercetin
sulforaphan
releas
plant
cell
wall
activ
enzym
myrosinas
via
cook
chew
compound
multipl
cellular
target
antioxid
activ
phase
ii
detoxif
enzym
antiinflammatori
agent
induc
apoptosi
role
jame
et
al
broccoli
use
exampl
nutrit
genom
approach
convey
consum
dietari
regim
market
posit
affect
health
ferguson
schlothauer
end
section
quot
broccoli
former
us
presid
dowd
march
presid
georg
h
w
bush
respons
queri
broccoli
ban
impos
upon
air
forc
one
said
like
broccoli
like
sinc
littl
kid
mother
made
eat
presid
unit
state
go
eat
broccoli
fact
presid
might
supertast
peopl
find
brussel
sprout
unbear
bitter
carri
variant
bitter
tast
receptor
result
enhanc
innat
immun
lee
et
al
effect
sulforaphan
csc
shown
sulforaphan
shown
inhibit
human
breast
csc
cell
line
vitro
vivo
li
et
al
spheroid
cultur
inhibit
well
aldh
express
nodscid
mous
xenograft
two
success
gener
elegantli
show
decreas
tumor
volum
increas
surviv
mgkg
daili
day
experi
sulforaphan
inhibit
spheroid
cultur
human
pancreat
csc
cell
line
vitro
vivo
rausch
et
al
sulforaphan
inhibit
renew
pancreat
cancer
stem
cell
vitro
inhibit
sonic
hedgehog
signal
pathway
rodova
et
al
nude
mice
xenograft
experi
sulforaphan
mgkg
cotreat
multikinas
inhibitor
sorafenib
mgkg
daili
day
experi
reduc
tumor
size
via
inhibit
pathway
rausch
et
al
research
group
also
extend
report
pancreat
csc
includ
result
prostat
csc
deriv
cell
line
kallifatidi
et
al
sulforaphan
ad
vitro
taxol
cisplatin
gemcitabin
flurouracil
doxorubicin
target
specif
csc
normal
cell
primari
human
fibroblast
umbil
vein
endotheli
cell
affect
vivo
nude
mice
xenograft
pancreat
csc
use
sulforaphan
combin
gemcitabin
mgkg
consequ
day
treatment
start
tumor
develop
observ
experi
differ
experi
pancreat
csc
pretreat
combin
xenograft
protocol
result
decreas
tumor
volum
kallifatidi
et
al
fact
sulforaphan
alon
could
reduc
human
pancreat
csc
growth
immunodefici
mice
inhibiton
sonic
hedgehog
signal
pathway
mgkg
day
day
experi
li
et
al
addit
solid
tumor
sulforaphan
enhanc
drug
efficaci
report
leukemia
chronic
myeloid
leukemia
csc
previous
resist
imatinib
kill
combin
imatinib
sulforaphan
vitro
via
activ
wnt
pathway
ro
induct
lin
et
al
mani
phytochem
may
serv
chemoprevent
agent
case
activ
csc
investig
addit
sulforaphan
anoth
import
phytochem
found
brassicac
veget
deriv
glucobrassicin
secondari
plant
metabolit
metabol
dimer
diindolmethan
dim
dim
relat
synthet
analogu
potenti
agent
chemoprevent
cancer
therapi
weng
et
al
safe
et
al
dim
inhibit
spheroid
cultur
format
csc
human
mous
cancer
cell
line
human
lung
carcinoma
murin
melanoma
vitro
dimtreat
melanoma
csc
show
smaller
tumor
volum
vivo
semov
et
al
quercetin
flavonol
found
common
fruit
veget
appl
broccoli
onion
antioxid
activ
review
safe
vivo
although
mutagen
vitro
harwood
et
al
boot
et
al
gibellini
et
al
report
quercetin
sensit
kill
cisplatin
human
ovarian
cancer
cell
line
chan
et
al
synergist
activ
human
pancreat
csc
discuss
tang
et
al
fact
quercetin
inhibit
spheroid
cultur
pancreat
csc
exhibit
synergist
effect
sulforaphan
nude
mice
xenograft
quercetin
sulforaphan
decreas
tumor
size
zhou
et
al
quercetin
also
target
heat
shock
protein
human
breast
csc
inhibit
spheroid
cultur
inhibitor
geldanamycin
enhanc
quercetin
lee
et
al
human
lung
csc
cell
line
xenograft
nodscid
mice
tumor
volum
decreas
treatment
quercetin
cisplatin
gemcitabin
hsu
et
al
cucurbitacin
cellperm
triterpenoid
compound
found
member
cucurbitacea
famili
cucumb
squash
melon
pumpkin
well
brassicac
veget
investig
taiwan
show
effect
csc
head
neck
squamou
cell
carcinoma
chen
et
al
well
csc
lung
cancer
hsu
et
al
thyroid
cancer
tseng
et
al
pediatr
brain
cancer
medulloblastoma
chang
et
al
cellular
target
cytokin
pathway
lupeol
anoth
triterpen
found
fruit
veget
research
group
hong
kong
demonstr
effect
csc
liver
cancer
lee
et
al
cellular
target
phosphatas
tensin
homologu
pten
protein
kinas
b
akt
pathway
extend
purifi
phytochem
plant
extract
blueberri
prepar
fed
mice
shown
effect
toward
csc
sera
blueberryf
anim
inhibit
spheroid
cultur
human
breast
csc
montal
et
al
pomegran
extract
also
inhibit
mous
mammari
csc
vitro
dai
et
al
summari
individu
phytochem
plant
extract
fruit
veget
spice
beverag
may
har
inhibit
csc
cellular
target
may
vari
depend
cancer
type
list
probabl
molecular
target
phytochem
csc
found
tabl
addit
dietari
phytochem
mani
molecul
target
csc
start
compound
isol
plant
speci
parthenolid
ptl
feverfew
plant
tanacetum
parthenium
commonli
use
herbal
medicin
ptl
target
human
acut
myelogen
leukemia
stem
cell
guzman
et
al
inhibitor
inhibit
human
breast
csc
cell
line
zhou
et
al
screen
silico
compound
similar
effect
gene
express
ptl
reveal
other
includ
celastrol
found
thunder
god
vine
tripterygium
wilfordii
use
chines
herbal
medicin
hassan
et
al
anoth
compound
berberin
plant
goldens
hydrasti
canadensi
chines
goldthread
copti
chinensi
also
use
herbal
medicin
target
sp
cell
kim
et
al
sp
cell
also
inhibit
alkaloid
oxymatrin
chines
herbal
medic
plant
sophora
flavescen
zhang
et
al
eriocalyxin
analogu
natur
diterpen
chines
herbal
medic
plant
isodon
eriocalyx
inhibit
human
ovarian
csc
via
inhibit
leizer
et
al
cyclopamin
corn
lili
veratrum
californicum
target
glioblastoma
csc
inhibit
hedgehog
pathway
bar
et
al
howev
note
cyclopamin
teratogen
caus
holoprosencephali
cyclopia
silybin
alia
silibinin
flavonoid
compound
herbal
medic
plant
milk
thistl
silybum
marianum
phytochem
target
colorect
csc
wang
et
al
butein
chalconoid
compound
chines
lacquer
tree
toxicodendron
vernicifluum
aromataseinhibit
effect
target
human
breast
csc
cioc
et
al
gossypol
polyphenol
cotton
plant
genu
gossypium
one
time
test
male
contracept
target
prostat
csc
via
activ
gene
regulatori
protein
volat
et
al
studi
obviou
mani
phytochem
target
csc
differ
cancer
addit
plant
molecul
target
csc
found
sourc
omf
secondari
metabolit
soil
fungu
penicillium
pinophilum
inhibit
spheroid
cultur
human
breast
csc
cell
line
buommino
et
al
thu
fungal
metabolit
may
act
csc
vitamin
target
csc
retino
acid
metabolit
vitamin
molecul
essenti
growth
develop
also
induc
cell
differenti
alltran
retino
acid
atra
inhibit
human
breast
csc
ginesti
et
al
atra
stealth
liposom
prevent
relaps
breast
cancer
aris
breast
csc
li
et
al
gemini
vitamin
vitamin
analogu
target
human
breast
csc
et
al
gammatocotrienol
vitamin
e
constitu
target
human
prostat
csc
luk
et
al
drug
may
also
target
csc
telomeras
inhibitor
imetelstat
inhibit
breast
pancreat
csc
joseph
et
al
statin
includ
simvastatin
lovastatin
suppress
abnorm
human
embryon
stem
cell
thu
may
play
role
csc
inhibit
gauthaman
et
al
probabl
signific
drug
report
thu
far
target
csc
metformin
hirsch
et
al
vazquezmartin
et
al
iliopoulo
et
al
metformin
current
use
treat
diabet
definit
futur
applic
csc
dowl
et
al
highthroughput
screen
assay
current
avail
compound
establish
embryon
csc
one
human
embryon
stem
cell
screen
retino
acid
other
found
modul
express
desbord
et
al
breast
csc
screen
salinomycin
found
target
csc
compound
origin
isol
streptomyc
albu
ionophor
ad
chicken
feed
coccidiostat
control
protozoan
parasit
poultri
gupta
et
al
anoth
ovarian
csc
screen
clinic
approv
drug
compound
niclosamid
found
target
csc
yo
et
al
origin
develop
molluscicid
snail
intermedi
host
blood
fluke
parasit
caus
schistosomiasi
anthelminth
cestod
tapeworm
niclosamid
proton
carrier
mode
action
also
activ
virus
one
caus
sever
acut
respiratori
syndrom
sar
jurgeit
et
al
combin
normal
csc
screen
antipsychot
drug
thioridazin
shown
target
csc
wherea
salinomycin
target
normal
csc
sachlo
et
al
expect
compound
target
csc
uncov
futur
screen
complementari
approach
look
novel
sourc
target
csc
along
line
research
extract
marin
spong
cramb
cramb
shown
target
pancreat
prostat
csc
otting
et
al
thu
unusu
anim
plant
speci
may
yield
novel
molecul
target
csc
phytochem
compound
target
csc
review
discuss
desir
properti
need
applic
cancer
therapi
topic
concern
antagonist
effect
combin
therapi
multipl
molecular
target
safeti
bioavail
wherea
synergist
effect
among
phytochem
welcom
cancer
prevent
therapi
liu
hemaiswarya
dobl
antagonist
effect
use
curcumin
resveratrol
egcg
exampl
curcumin
synergist
resveratrol
colon
cancer
inhibit
majumdar
et
al
antagonist
egcg
toward
keratinocyt
egcg
enhanc
keratinocyt
differenti
wherea
curcumin
inhibit
differenti
curcumin
activ
apoptosi
wherea
egcg
eckert
et
al
potenti
antagonist
effect
among
compound
must
analyz
combin
use
despit
potenti
oppos
effect
individu
phytochem
combinatori
applic
promot
suggest
specif
combin
phytochem
may
far
effect
protect
cancer
isol
compound
combin
dietari
chemoprevent
agent
sometim
result
signific
activ
concentr
singl
agent
inact
de
kok
et
al
thu
combinatori
use
phytochem
attract
approach
target
csc
csc
multipl
molecular
target
dietari
phytochem
curcumin
resveratrol
egcg
tend
aim
multitud
cellular
target
perhap
characterist
definit
mechan
action
avail
despit
decad
research
francyguilford
pezzuto
multitarget
natur
phytochem
may
advantag
target
csc
multifacet
mode
action
may
hinder
cell
abil
develop
resist
phytochem
safe
dietari
phytochem
interact
drug
transport
drug
metabol
enzym
known
phase
phase
ii
enzym
potenti
toxic
safeti
phytochem
major
concern
exampl
antioxid
capac
ro
howev
special
condit
also
exhibit
prooxid
capac
wherea
ro
harm
gener
remov
much
ro
interfer
bodi
function
seen
warn
present
scientist
food
industri
finley
et
al
emphasi
put
cancer
chemoprevent
use
safeti
group
phytochem
review
verschoyl
et
al
curcumin
given
cancer
patient
mgday
month
mgday
month
minor
advers
effect
seen
egcg
daili
oral
dose
week
mgday
volunt
caus
minor
advers
effect
resveratrol
singl
oral
dose
g
volunt
caus
minor
advers
effect
boocock
et
al
howev
high
consumpt
dietari
phytochem
consid
caution
take
account
dosag
regim
toxic
metabol
convers
transport
mechan
tissu
avail
synergist
interact
drug
interfer
key
enzym
receptor
metabol
pathway
normal
gi
microflora
priyadarsini
nagini
extens
toxicolog
test
recommend
phytochem
taken
cancer
chemoprevent
agent
longterm
basi
healthi
individu
bioavail
dietari
phytochem
bioavail
may
differ
depend
condit
vari
pure
compound
plant
extract
mixtur
food
compon
egcg
vs
green
tea
extract
genistein
vs
soymilk
tofu
quercetin
vs
appl
cider
appl
manach
et
al
phytochem
plant
polyphenol
effect
vivo
although
signific
limit
observ
vitro
williamson
manach
howev
possibl
design
appropri
interact
affect
bioavail
phytochem
vivo
scholz
williamson
enhanc
curcumin
efficaci
piperin
previous
mention
use
oral
gavag
plu
starvat
empti
stomach
enhanc
curcumin
uptak
mice
chan
et
al
adapala
chan
demonstr
vivo
inhibit
inflammatori
ino
murin
liver
benefici
outcom
exacerb
murin
viscer
leishmaniasi
protozoan
parasit
diseas
detriment
outcom
last
report
recommend
caution
regard
potenti
clinic
use
curcumin
may
reactiv
latent
infect
second
look
bioavail
relat
concept
hormesi
effect
curcumin
describ
exampl
xenohormesi
salvioli
et
al
concept
hormesi
suggest
fundament
natur
curv
neither
linear
threshold
rather
ushap
jshape
show
low
dose
stimulatori
respons
known
hormet
effect
repres
overcompens
respons
disrupt
homeostasi
calabres
baldwin
phytochem
among
estim
secondari
product
natur
pesticid
propos
human
ancestor
evolv
gener
defens
mechan
low
level
phytochem
enabl
consumpt
mani
differ
plant
speci
contain
variabl
level
natur
pesticid
carcinogen
without
subsequ
ill
health
trace
phytochem
found
fruit
veget
may
potenti
immun
system
help
protect
cancer
trewava
stewart
biphas
dose
respons
observ
high
concentr
phytochem
toxic
wherea
subtox
dose
may
induc
adapt
stress
respons
activ
signal
pathway
result
increas
express
gene
encod
cytoprotect
protein
suggest
hormet
mechan
action
may
underli
mani
health
benefit
phytochem
mattson
benefit
would
includ
action
csc
among
compound
undergo
clinic
trial
success
rate
anticanc
drug
less
lowest
compar
drug
cardiovascular
central
nervou
system
infecti
diseas
take
billion
bring
drug
market
bhattacharje
exampl
anticanc
drug
plant
taxol
vinblastin
plant
rich
sourc
drug
small
fraction
immens
divers
plant
metabol
explor
product
new
medicin
product
import
human
wellb
de
luca
et
al
therefor
new
phytochem
target
csc
expect
futur
meantim
current
avail
phytochem
need
definit
studi
evidencebas
approach
favor
higdon
fact
fiction
phytochem
must
differenti
et
al
phytochem
may
act
concert
convent
drug
visual
follow
metaphor
use
low
concentr
phytochem
caus
multipl
wound
without
kill
csc
nevertheless
treatment
increas
csc
vulner
magic
bullet
repres
chemotherapeut
drug
russo
sens
dietari
phytochem
may
serv
adjuv
anticanc
agent
practic
minim
side
effect
urgent
need
bridg
gap
appar
vitro
efficaci
clinic
use
dietari
phytochem
manson
et
al
biomark
decis
dosag
clinic
trial
still
work
scott
et
al
exampl
transcript
analys
microarray
gene
express
peripher
blood
mononuclear
cell
pmbc
dietari
intervent
studi
result
yet
clear
confirm
candid
gene
relat
diseas
risk
de
mello
et
al
current
statu
dietari
phytochem
cancer
chemoprevent
focu
lie
identif
molecular
mechan
cellular
target
concept
combin
chemoprevent
multipl
agent
consumpt
whole
food
becom
increasingli
attract
area
studi
mehta
et
al
concern
whole
food
consumpt
current
us
dietari
guidelin
illustr
myplat
advic
cover
half
plate
fruit
veget
willett
ludwig
europ
mediterranean
diet
pyramid
today
plantbas
core
dietari
pattern
consum
fruit
veget
everyday
bachfaig
et
al
effect
fruit
veget
cancer
chemoprevent
earli
casecontrol
studi
tout
reduct
cancer
risk
recent
prospect
cohort
studi
show
weak
associ
exampl
pool
analysi
cohort
studi
pancreat
cancer
conclud
fruit
veget
intak
adulthood
associ
reduc
pancreat
cancer
risk
koushik
et
al
therefor
turmoil
produc
section
weak
undetect
associ
fruit
veget
risk
cancer
exclud
possibl
one
small
group
fruit
veget
specif
substanc
food
import
protect
effect
willett
latter
point
well
proven
catalogu
dietari
phytochem
target
csc
cover
review
furthermor
although
evid
benefit
fruit
veget
cancer
wane
data
support
benefit
cardiovascular
diseas
accumul
willett
septemb
unit
nation
gener
assembl
conven
high
level
meet
noncommunic
diseas
ncd
four
main
ncd
diseas
cancer
chronic
lung
diseas
three
five
peopl
worldwid
caus
great
socioeconom
harm
within
countri
particularli
develop
nation
septemb
scienc
magazin
publish
special
section
includ
cover
photo
topic
diseas
prevent
ash
et
al
one
contribut
articl
titl
noncommunic
diseas
prevent
suggest
effect
approach
largescal
ncd
prevent
includ
among
increas
consumpt
fresh
fruit
veget
ezzati
riboli
best
time
start
eat
fruit
veget
first
ladi
michel
obama
start
campaign
childhood
obes
willett
ludwig
suggest
research
focu
sharpli
specif
fruit
veget
constitu
earlier
period
life
willett
alreadi
mention
genistein
effect
fetal
dna
methyl
thu
come
matern
womb
novel
target
cancer
prevent
simmen
simmen
dietari
intervent
prior
pregnanc
may
confer
cancer
chemoprevent
first
sentenc
discuss
myth
realiti
aspect
dietari
molecul
begin
bc
statement
hippocr
let
thi
food
thi
medicin
thi
medicin
thi
food
neergheenbhujun
et
al
end
chapter
comment
cell
differenti
csc
octob
nobel
prize
physiolog
medicin
announc
discoveri
cell
reprogram
abbott
john
gurdon
publish
work
plastic
differenti
nucleu
amphibian
nucleu
tadpol
intestin
cell
replac
egg
nucleu
gener
frog
shinya
yamanaka
publish
work
reprogram
differenti
cell
type
mous
mous
fibroblast
becam
embryon
stem
cell
ad
four
gene
latter
work
transfer
human
induc
pluripot
stem
ip
cell
import
futur
clinic
applic
differenti
state
cell
dynam
csc
play
essenti
role
maintain
particular
tumor
dietari
phytochem
specif
fruit
veget
avail
destroy
csc
revers
stem
characterist
induc
cell
differenti
chemoprevent
cancer
